Ticker brief

MRNX

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
9
authors 14d
8
crowd 14d
+0.24

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-22 · now +0.70 (−1 bearish … +1 bullish)
Who spoke8
authorgradetrader scoresignalsmean sent
@fundmyfundB-1.582+0.72
@DekmarTradesC-1.241+0.30
@longriverCMB-0.851+0.25
@stockgutterB+0.781-0.20
@DeepSailCapitalA-0.471+0.10
@TCMLLCB-0.521-0.10
@NirAoo7C-1.181+0.40
@ivanhoffC-1.311+0.70
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-22@ivanhoff+0.70Reports Moderna's positive Phase 3 melanoma-vaccine results and a 100% high-volume gap that drove its leveraged ETF higher.·
2026-08-21@NirAoo7+0.40Identifies MRNX as a 2x leveraged long vehicle for more exposure·
2026-08-20@TCMLLC-0.10Long MRNA at 131.33, stop 128.41, first target 134.25; avoiding thin MRNX. — Provides a concrete MRNA entry, stop, position sizing and upside target.·
2026-08-19@DeepSailCapital+0.10Reports an 18% borrow rate and 353% daily rise.·
2026-08-19@stockgutter-0.20Notes a reasonably priced 2x ETF but says borrow is currently unavailable.·
2026-08-19@longriverCM+0.25Highlights a 357% one-day move without claiming a realized trade.·
2026-08-19@fundmyfund+0.80Jokes that nightly-news viewers may chase MRNA while highlighting MRNX's 340% gain.·
2026-08-19@fundmyfund+0.65Discloses being long both Moderna common shares and its leveraged ETF before the move.·
2026-08-19@DekmarTrades+0.30Positively presents MRNA and smaller related ETFs as tradable alternatives.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.